Skip to content

Ketamine: all studies

Page 444 of 448: studies 4,431 to 4,440 of 4,475, newest first. Back to the ketamine overview

Research

Advances and Pathophysiological Models of Hallucinogenic Drug Actions in Humans: A Preamble to Schizophrenia Research

Pharmacopsychiatry July 1, 1998 Franz X. Vollenweider 131 citations

Recent research into the pharmacological mechanism of hallucinogens (LSD, psilocybin) and dissociative anesthetics (PCP, ketamine) suggest that multiple neurotransmitter systems are involved in drug-induced and possibly also in naturally occurring psychoses. Specifically, animal models suggest that a dysbalance between serotonin, glutamate, and dopamine in the limbic cortico-striato-thalamic...

Is the Near-Death Experience Only N-Methyl-D-Aspartate Blocking?

Journal of Near-Death Studies March 1, 1997 P. Fenwick

Karl Jansen's interesting hypothesis that near-death experiences (NDEs) result from blockade of the N-methyl-D-aspartate receptor has several weaknesses. Some NDEs occur to individuals who are neither near death nor experiencing any event likely to upset cerebral physiology as Jansen proposed; thus his hypothesis applies only to a subset of NDEs that occur in catastrophic circumstances. For...

Dizocilpine-like discriminative stimulus effects of low-affinity uncompetitive NMDA antagonists.

Neuropharmacology 1996 K A Grant, G Colombo, J Grant et al.

The dizocilpine-like discriminative stimulus effects of a variety of channel blocking (uncompetitive) N-methyl-D-aspartate (NMDA) receptor antagonists were examined in rats trained to discriminate dizocilpine (0.17 mg/kg, i.p) from saline in a two-lever operant procedure. The dissociative anesthetic-type NMDA antagonists dizocilpine (ED50 0.05 mg/kg), phencyclidine (ED50 3.4 mg/kg) and ketamine...

Curing agents

Additives for Polymers March 1, 1994

An analytical method for determining traditional and emerging drugs of abuse in particulate matter, sewage sludge and sediment has been developed and validated. A total of 41 drugs of abuse and metabolites including cocainics, tryptamines, amphetamines, arylcyclohexylamines, cathinones, morphine derivatives, pyrrolidifenones derivatives, entactogens, piperazines and other psychostimulants were...

DOI: 10.1016/0306-3747(94)90197-x (opens in new tab) Benzoylecgonine Chromatography Solid phase extraction Extraction chemistry +3

Tolerance to the cataleptic effect of the N-methyl-D-aspartate (NMDA) receptor antagonists in pigeons: cross-tolerance between PCP-like compounds and competitive NMDA antagonists.

Journal of Pharmacology and Experimental Therapeutics November 1, 1992 Y. Lu, C. France, James H Woods

The effects of chronic administration of phencyclidine (PCP) or CGS 19755 (cis-4-phosphonomethyl-2-piperidine-carboxylic acid) on the cataleptic effects of N-methyl-D-aspartate (NMDA) receptor antagonists were studied in pigeons. PCP, a channel blocker of the NMDA receptor complex, or CGS 19755, a competitive NMDA antagonist, was administered i.m. to separate groups of pigeons each day....

Chemical dissociation of human awareness: focus on non-competitive NMDA receptor antagonists.

Journal of Psychopharmacology January 1992 E F Domino

Since the mid-1950s the pharmaceutical industry has developed a number of chemicals, including phencyclidine, ketamine and related arylcyclohexylamines (PCE and TCP), dizocilpine (MK-801), N-allylnormetazocine [ NANM, (±)SKF-10,047], etoxadrol, dioxadrol and its enantiomers dexoxadrol and levoxadrol, which produce a constellation of unusual behavioral effects in animals and man. The compounds...

The combination of psychedelic and aversive approaches in alcoholism treatment: The affective contra-attribution method

Alcoholism Treatment Quarterly 1992

Abstract The "Affective Contra-Attribution" method of alcoholism treatment consists of three stages: (1) an introductory psychotherapeutic stage; (2) psychedelic treatment with ketamine utilization: and (3) therapist led group discussion of the patients' psychedelic experiences. The stages of psychedelic treatment include psychotherapeutic dialogue with the patient within the context of the...

NMDA Antagonist Neurotoxicity: Mechanism and Prevention

Science December 6, 1991 J. W. Olney, J. Labruyere, G. Wang et al. 850 citations

Antagonists of the N-methyl-D-aspartate (NMDA) subtype of glutamate receptor, including phencyclidine (PCP) and ketamine, protect against brain damage in neurological disorders such as stroke. However, these agents have psychotomimetic properties in humans and morphologically damage neurons in the cerebral cortex of rats. It is now shown that the morphological damage can be prevented by certain...

Recent advances in the phencyclidine model of schizophrenia

American Journal of Psychiatry October 1, 1991 2,916 citations

OBJECTIVE: Phencyclidine (PCP, "angel dust") induces a psychotomimetic state that closely resembles schizophrenia. As opposed to amphetamine-induced psychosis, PCP-induced psychosis incorporates both positive (e.g., hallucinations, paranoia) and negative (e.g., emotional withdrawal, motor retardation) schizophrenic symptoms. PCP-induced psychosis also uniquely incorporates the formal thought...

[3H]1-[2-(2-thienyl)cyclohexyl]piperidine labels two high-affinity binding sites in human cortex: further evidence for phencyclidine binding sites associated with the biogenic amine reuptake complex.

Synapse August 1, 1991 H C Akunne, A A Reid, A Thurkauf et al.

Previous work demonstrated two high-affinity PCP binding sites in guinea pig brain labeled by [3H]TCP (1-(1-[2-thienyl]cyclohexyl)piperidine): site 1 (N-methyl-D-aspartate [NMDA]-associated) and site 2 (dopamine-reuptake complex associated). The present study examined brain membranes prepared from various species, including human, for the presence of site 2, defined as binding in the presence...